Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Meningeal Carcinomatosis
Interventions: DRUG: 2B3-101
Sponsor: The Netherlands Cancer Institute